MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Biofrontera Inc. Common Stock

BFRI

#3845
Biofrontera Inc. Common Stock
0.91
+1.11%
Sector:
Base:
Profit Currency:
Daily Range
0.91
0.91
Year Range
0.54
1.18
Daily Change
+1.11%
Monthly Change
-8.08%
6 month change
+5.81%
Year Change
-7.14%
Previous Close
0.90
Open
0.91
Bid
Ask
Low
0.91
High
0.91
Volume
3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. BFRI
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Zacks Zacks
BFRI
2026.02.05
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks Zacks
BFRI BKD
2026.02.05
Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year?
Investing Investing
BFRI
2026.01.13
Biofrontera reports record quarterly revenue in Q4 2025
Investing Investing
BFRI
2026.01.08
Biofrontera reaches database lock milestone for skin treatment studies
Benzinga Benzinga
BIDU BFRI SOC SLS MLEC
2026.01.02
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Aimei Health Technology (NASDAQ:AFJK), Adlai Nortye (NASDAQ:ANL)
Investing Investing
BFRI
2025.12.18
Biofrontera completes transfer of FDA approvals for Ameluz and RhodoLED
Investing Investing
BFRI
2025.12.04
Biofrontera completes phase 1 study for expanded Ameluz treatment areas
Investing Investing
BFRI
2025.12.02
Biofrontera submits sNDA to FDA for skin cancer treatment
Investing Investing
BFRI
2025.11.14
Biofrontera stock holds Buy rating at Benchmark despite Q3 net loss
Zacks Zacks
ROIV BFRI
2025.11.10
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates
Investing Investing
BFRI
2025.11.07
Biofrontera divests Xepi cream license to Pelthos for up to $10 million
Benzinga Benzinga
BFRI LGND
2025.11.07
EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch - Pelthos Therapeutics (AMEX:PTHS)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd